Literature DB >> 16131451

Ewing's sarcoma family of tumors.

María Jesús Antuña García1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16131451     DOI： 10.1007/BF02710174

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.340


× No keyword cloud information.
  66 in total

Review 1.  Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family.

Authors:  E de Alava; W L Gerald
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

2.  Megatherapy in children with high-risk Ewing's sarcoma in first complete remission.

Authors:  L Madero; A Muñoz; J Sánchez de Toledo; M A Díaz; M S Maldonado; J J Ortega; M Ramírez; E Otheo; A Benito; S Salas
Journal:  Bone Marrow Transplant       Date:  1998-04       Impact factor: 5.483

3.  Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

Authors:  J F Kuttesch; L H Wexler; R B Marcus; D Fairclough; L Weaver-McClure; M White; L Mao; T F Delaney; C B Pratt; M E Horowitz; L E Kun
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

4.  High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

Authors:  P A Meyers; M D Krailo; M Ladanyi; K W Chan; S L Sailer; P S Dickman; D L Baker; J H Davis; R B Gerbing; A Grovas; C E Herzog; K L Lindsley; W Liu-Mares; J B Nachman; L Sieger; J Wadman; R G Gorlick
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

5.  Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.

Authors:  E Anders Kolb; Brian H Kushner; Richard Gorlick; Caroline Laverdiere; John H Healey; Michael P LaQuaglia; Andrew G Huvos; Jing Qin; Ha Thanh Vu; Leonard Wexler; Suzanne Wolden; Paul A Meyers
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

6.  Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

Authors:  A Zoubek; B Dockhorn-Dworniczak; O Delattre; H Christiansen; F Niggli; I Gatterer-Menz; T L Smith; H Jürgens; H Gadner; H Kovar
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

Review 7.  Biology of pediatric peripheral neuroectodermal tumors.

Authors:  C J Thiele
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

8.  Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors.

Authors:  Matthew J Krasin; Carlos Rodriguez-Galindo; Andrew M Davidoff; Catherine A Billups; Christine E Fuller; Michael D Neel; Larry E Kun; Thomas E Merchant
Journal:  Pediatr Blood Cancer       Date:  2004-09       Impact factor: 3.167

9.  Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.

Authors:  Iranzu González; Enrique J Andreu; Angel Panizo; Susana Inogés; Ana Fontalba; José Luis Fernández-Luna; Mirella Gaboli; Luis Sierrasesúmaga; Salvador Martín-Algarra; Javier Pardo; Felipe Prósper; Enrique de Alava
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

10.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials.

Authors:  Andreas Schuck; Susanne Ahrens; Michael Paulussen; Michaela Kuhlen; Stefan Könemann; Christian Rübe; Winfried Winkelmann; Rainer Kotz; Jürgen Dunst; Normann Willich; Heribert Jürgens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038
View more
  1 in total

1.  Dural metastasis of Ewing's sarcoma.

Authors:  Atef Ben Nsir; Mohamed Boughamoura; Mezri Maatouk; Mohamed Kilani; Nejib Hattab
Journal:  Surg Neurol Int       Date:  2013-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.